Global Peripheral Vascular Devices Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type (Peripheral Vascular Stents, Peripheral Transluminal Angioplasty (PTA) Balloon Catheters, Peripheral Transluminal Angioplasty (PTA) Guidewires, Embolic Protection Devices, Others), By End User (Hospitals And Clinics, Ambulatory Surgery Centres), And Geography - Forecasts From 2021 To 2026

  • Published : Oct 2021
  • Report Code : KSI061611749
  • Pages : 112

The global peripheral vascular devices market is projected to grow at a CAGR of 4.63% to reach US$6.849 billion by 2026, from US$4.988 billion in 2019.

Medical devices used to treat peripheral vascular disease are known as peripheral vascular devices (PVD). PVD is characterized by plaque accumulation, which results in artery constriction or blockage and inadequate blood flow. Peripheral Vascular Stents, Peripheral Transluminal Angioplasty (PTA) Balloon Catheters, Peripheral Transluminal Angioplasty (PTA) Guidewires, Embolic Protection Devices are some of the devices used to treat PVD. Surgical or minimally invasive catheter-based methods can be used to treat peripheral vascular devices. Over the next few years, the peripheral vascular devices market is projected to be driven by rapid growth in the elderly population and an increase in the incidence of peripheral vascular disorders. In addition, the rising incidence of diabetes and increased demand for Minimally Invasive Endovascular treatments are expected to propel the market forward in the approaching years. Furthermore, rising diabetes occurrences and the approval of new and improved medicines are expected to propel the market forward throughout the anticipated period. One of the primary causes driving demand for peripheral vascular devices is the increasing rise of the senior population, which is at a higher risk of acquiring peripheral vascular illnesses such as atherosclerosis and aneurysms. This is because, as people become older, hereditary and lifestyle factors can cause plaque to build up in the arteries. According to research published by the US National Library of Medicine, more than 202 million individuals worldwide suffer from peripheral vascular disease, with more than two-thirds of them living in low- and middle-income nations. The incidence of peripheral vascular disorders is projected to rise further in the coming years due to the rising elderly population in all major areas throughout the world. As a result, throughout the projection period, demand and acceptance of peripheral vascular devices will grow in key markets.

The most profitable market for peripheral vascular devices is expected to be the North America and Asia-Pacific region. The availability of a huge patient pool with unmet medical requirements is one of the major reasons contributing to this region's quickest development. Furthermore, the peripheral vascular devices market is anticipated to increase as the healthcare environment in Asian nations improves, along with GDP growth and government efforts. Furthermore, the rising incidence of peripheral vascular illnesses linked to obesity, diabetes, and hypertension, as well as the growing elderly population, need for less invasive treatment alternatives, and the prevalence of disease-causing lifestyles, are all important contributors boosting the market growth in the region.

Growth Factors

  • Growth opportunities in emerging economies to propel the market growth

One of the major reasons for the growth of the global peripheral vascular devices market is growing growth opportunities in emerging economies owing to less rigorous regulatory rules and minimal competition, emerging markets like as China, India, Singapore, and Brazil are projected to develop rapidly in the future years. The growing population among these countries and the high prevalence of peripheral diseases are further fueling the market growth for global peripheral vascular devices. Medical device demand in emerging nations is rising at a faster rate than in industrialized ones. Due to the growth of the private healthcare sector to meet the requirements of the growing middle-class population and rising disposable incomes, the medical equipment business in emerging nations is quickly growing.

Impact of COVID–19

The COVID-19 pandemic has had a great impact on the world as a whole and has led to economic breakdown and loss of life. Patient visits to hospitals have decreased considerably as a result of the lockdown in several nations. As a result, there are fewer diagnostic tests available. This has resulted in a further drop in sales of peripheral vascular devices. Elective operations have been postponed in a majority of nations throughout the world to avoid the spread of COVID-19. Many peripheral vascular interventional treatments have been postponed due to the fact that the bulk of these operations are elective which is obstructing the growth of the peripheral vascular devices market is the course of the pandemic. Supply lines were also affected by shuttered production sites owing to lockdowns, and clinical trial recruitment was down.

Competitive Insights

The market leaders for the pretreatment coating market are Medtronic, Terumo, Abbott, Cordis, Biomerics, Cardiva Medical Inc., Vasorum Ltd., Biotronik GMBH & CO.KG, Boston Scientific Corporation and TZ Medical Inc..

Global Peripheral Vascular Devices Market Scope:

Report Metric Details
 Market size value in 2019  US$4.988 billion
 Market size value in 2026  US$6.849 billion
 Growth Rate  CAGR of 4.63% from 2019 to 2026
 Base year  2019
 Forecast period  2021–2026
 Forecast Unit (Value)  USD Billion
 Segments covered  Type, End-Users, And Geography
 Regions covered  North America, South America, Europe, Middle East and Africa, Asia Pacific
 Companies covered  Medtronic, Terumo, Abbott, Cordis, Biomerics, Cardiva Medical, Inc., Vasorum Ltd,   Biotronik GMBH & CO.KG, Boston Scientific Corporation, TZ Medical, Inc
 Customization scope  Free report customization with purchase

Segmentation

  • By Type
    • Peripheral Vascular Stents
    • Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
    • Peripheral Transluminal Angioplasty (PTA) Guidewires
    • Embolic Protection Devices
    • Others
  • By End-Users
    • Hospitals and Clinics
    • Ambulatory Surgical Centers
  •  By Geography
    • North America
      • USA
      • Canadá
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • UK
      • Germany
      • France
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • Israel
      • Others
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Indonesia
      • Taiwan
      • Thailand
      • Others

Frequently Asked Questions (FAQs)

Q1. What will be the peripheral vascular devices market size by 2026?
A1. The global peripheral vascular devices market is expected to reach a total market size of US$6.849 billion in 2026.


Q2. What are the growth prospects for peripheral vascular devices market?
A2. The peripheral vascular devices market is expected to grow at a CAGR of 4.63% over the forecast period.


Q3. What is the size of global peripheral vascular devices market?
A3. Peripheral Vascular Devices Market was valued at US$4.988 billion in 2019.


Q4. What factors are anticipated to drive peripheral vascular devices market growth?
A4. The growing global geriatric population is expected to drive the global peripheral vascular devices market growth.


Q5. Who are the major players in the peripheral vascular devices market?
A5. Prominent/major key market players in the global peripheral vascular devices market include Medtronic, Terumo, Abbott, and Cordis among others.


1. Introduction
1.1. Market Definition
1.2. Market Segmentation

2. Research Methodology
2.1. Research Data
2.2. Assumptions

3. Executive Summary
3.1. Research Highlights

4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. The threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. Peripheral Vascular Devices Market Analysis, By Type
5.1. Introduction
5.2. Peripheral Vascular Stents
5.3. Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
5.4. Peripheral Transluminal Angioplasty (PTA) Guidewires
5.5. Embolic Protection Devices
5.6. Others

6. Peripheral Vascular Devices Market Analysis, By End-User
6.1. Introduction
6.2. Hospitals & Clinics
6.3. Ambulatory Surgical Centers

7. Peripheral Vascular Devices Market Analysis, By Geography 
7.1.  Introduction
7.2.  North America
7.2.1. United States
7.2.2. Canada
7.2.3. Mexico
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Others
7.4. Europe
7.4.1. UK
7.4.2. France
7.4.3. Germany
7.4.4. Spain
7.4.5. Others
7.5. The Middle East and Africa
7.5.1. Saudi Arabia
7.5.2. Israel
7.5.3. Others
7.6. Asia Pacific
7.6.1. Japan
7.6.2. China
7.6.3. India
7.6.4. South Korea
7.6.5. Thailand
7.6.6. Taiwan
7.6.7. Indonesia
7.6.8. Others

8.  Competitive Environment and Analysis
8.1. Major Players and Strategy Analysis
8.2.  Emerging Players and Market Lucrativeness
8.3.  Mergers, Acquisitions, Agreements, and Collaborations
8.4.  Vendor Competitiveness Matrix

9. Company Profiles
9.1. Medtronic
9.2. Terumo
9.3. Abbott
9.4. Cordis
9.5. Biomerics
9.6. Cardiva Medical Inc.
9.7. Vasorum Ltd.
9.8. Biotronik GMBH & CO.KG
9.9. Boston Scientific Corporation
9.10. TZ Medical Inc.

Medtronic

Terumo

Abbott

Cordis

Biomerics

Cardiva Medical Inc.

Vasorum Ltd.

Biotronik GMBH & CO.KG

Boston Scientific Corporation

TZ Medical Inc.